BAM
ABBV icon

Bosun Asset Management’s AbbVie ABBV Stock Holding History

Bosun Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$46.3K – 80
2025
Q3 		$46.3K Hold
200
– – 0.02% 70
2025
Q2 		$37.1K Hold
200
– – 0.01% 195
2025
Q1 		$41.9K Hold
200
– – 0.02% 192
2024
Q4 		$35.5K Buy
+200
New +$36.8K 0.02% 187

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bosun Asset Management's ABBV Position: Q2 2026 in Review

Bosun Asset Management reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $17.4K and leaving 3,580 shares worth $901K. The position accounts for 0.46% of the portfolio, ranked #30.

Bosun Asset Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.32M in Q1 2023. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Bosun Asset Management held 3,580 shares of AbbVie worth $901K as of Q2 2026.
  • Bosun Asset Management sold 81 AbbVie shares in Q2 2026, an estimated $17.4K.
  • AbbVie made up 0.46% of Bosun Asset Management's portfolio in Q2 2026, its #30 holding.
  • Bosun Asset Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Bosun Asset Management's AbbVie position peaked at $1.32M in Q1 2023.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Bosun Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.